These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 8534123)
1. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience. Prinz B; Behrens W; Hölzle E; Plewig G Arch Dermatol Res; 1995; 287(7):621-6. PubMed ID: 8534123 [TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience. Jiang SB; Dietz SB; Kim M; Lim HW Photodermatol Photoimmunol Photomed; 1999 Oct; 15(5):161-5. PubMed ID: 10540936 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis. Knobler R; Duvic M; Querfeld C; Straus D; Horwitz S; Zain J; Foss F; Kuzel T; Campbell K; Geskin L Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):250-7. PubMed ID: 22971190 [TBL] [Abstract][Full Text] [Related]
4. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. Gottlieb SL; Wolfe JT; Fox FE; DeNardo BJ; Macey WH; Bromley PG; Lessin SR; Rook AH J Am Acad Dermatol; 1996 Dec; 35(6):946-57. PubMed ID: 8959954 [TBL] [Abstract][Full Text] [Related]
6. The treatment of cutaneous T-cell lymphoma with photopheresis. Zic JA Dermatol Ther; 2003; 16(4):337-46. PubMed ID: 14686977 [TBL] [Abstract][Full Text] [Related]
7. Photopheresis in cutaneous T-cell lymphoma: five-year experience. Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838 [TBL] [Abstract][Full Text] [Related]
8. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma. Geskin L Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808 [TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution. Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649 [TBL] [Abstract][Full Text] [Related]
10. Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019. Girardi M; Carlson K; Huang X; Corman SL; Edmundson P; Schmier J; Kale HP; Raina R; Foss F J Dermatolog Treat; 2024 Dec; 35(1):2360568. PubMed ID: 38852942 [TBL] [Abstract][Full Text] [Related]
11. 75% Complete Response and 15% Partial Response to Extracorporeal Photopheresis Combined With Other Therapies in Resistant Early Stage Cutaneous T-Cell Lymphoma. Seremet S; Abhyankar S; Herd TJ; Aires D J Drugs Dermatol; 2016 Oct; 15(10):1212-1216. PubMed ID: 27741338 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. Zic JA; Stricklin GP; Greer JP; Kinney MC; Shyr Y; Wilson DC; King LE J Am Acad Dermatol; 1996 Dec; 35(6):935-45. PubMed ID: 8959953 [TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature. Quaglino P; Knobler R; Fierro MT; Savoia P; Marra E; Fava P; Bernengo MG Int J Dermatol; 2013 Nov; 52(11):1308-18. PubMed ID: 23786842 [TBL] [Abstract][Full Text] [Related]
14. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Suchin KR; Cucchiara AJ; Gottleib SL; Wolfe JT; DeNardo BJ; Macey WH; Bromley PG; Vittorio CC; Rook AH Arch Dermatol; 2002 Aug; 138(8):1054-60. PubMed ID: 12164743 [TBL] [Abstract][Full Text] [Related]
15. The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas. Atta M; Papanicolaou N; Tsirigotis P Transfus Apher Sci; 2012 Apr; 46(2):195-202. PubMed ID: 22067605 [TBL] [Abstract][Full Text] [Related]
16. CD209 Ni X; Austin M; Langridge T; Bojaxhi P; Bijani P; Wang X; Duvic M Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):290-298. PubMed ID: 32187738 [TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T Peacock A; Dehle F; Mesa Zapata OA; Prince HM; Gennari F; Taylor C Value Health; 2022 Jun; 25(6):965-974. PubMed ID: 35667784 [TBL] [Abstract][Full Text] [Related]
18. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma. Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases]. Owsianowski M; Garbe C; Ramaker J; Orfanos CE; Gollnick H Hautarzt; 1996 Feb; 47(2):114-23. PubMed ID: 8868455 [TBL] [Abstract][Full Text] [Related]
20. Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies. Russell-Jones R Br J Dermatol; 2000 Jan; 142(1):16-21. PubMed ID: 10651689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]